Compare medications

Max 4 meds. Sources include DailyMed labels; verify against official labeling. Last reviewed shown per row. On small screens the table defaults to a compact view—use “Show all columns” to view everything (scroll horizontally). Visit individual drug pages for narratives, printable summaries, and therapeutic drug monitoring notes.

Add up to 4 medications

0/4 selected

Browse catalog

Oral Antipsychotics

Second Generation Antipsychotics (SGAs)

First Generation Antipsychotics (FGAs)

Long‑acting Injectable Antipsychotics (LAIs)

Mood Stabilizers

Adjunctive Medications

Ketamine & rapid-acting antidepressants (2)

Benzodiazepines (12)

Sleep & circadian agents (14)

ADHD & wakefulness agents (14)

Substance use treatment & harm reduction (11)

Metabolic & weight management (4)

Other adjunctive medications (17)

Compact view hides Indications, MOA, PK, TDM, Monitoring, and Reviewed.

Medication	Indications (label)	Dosing highlights	MOA	PK	TDM	Risk flags	Monitoring	LAI options	Last reviewed
oxcarbazepineMood stabilizerBrands: Trileptal, Oxtellar XR View labelExact	Seizure disorders View labelExact	Acute mania: start 300 mg twice daily (IR); increase by 300 mg/day every 3–4 days to 900–1,200 mg/day, with experience limited above 1,800 mg/day in psychiatric populations.	Voltage-gated sodium channel modulator that decreases glutamatergic excitation; used off-label as a mood stabilizer and antiepileptic.	cytosolic reduction to MHD \| Single-dose mean 9 h	No	Sedation	Serum sodium at baseline and during titration (and after dose or medication changes), given high hyponatremia risk. Neurologic tolerability (dizziness, diplopia, ataxia) during titration; these symptoms often appear before clinically significant hyponatremia. Medication review for additive sodium-lowering agents (SSRIs, thiazides, desmopressin) and for contraceptive efficacy given CYP3A4/UGT induction. Rash or mucosal symptoms during early therapy; cross-reactivity with prior carbamazepine rash can occur and warrants heightened vigilance. Bone health for long-term therapy (vitamin D, calcium, and fall risk), especially in older adults or when other enzyme-inducing medications are used.	No	2025-12-29
carbamazepineMood stabilizerBrands: TEGRETOL View labelExact	Seizures (various types); trigeminal neuralgia; off‑label for bipolar mania (consult guidelines). View labelExact	Typical start is 200 mg BID; increase by 200 mg/day every 3–5 days to 800–1,200 mg/day (max 1,600 mg).	Voltage‑gated sodium channel blocker; reduces high‑frequency neuronal firing.	CYP3A4 (autoinduction), epoxide metabolite \| Steady-state mean 15 h	4000–12000 ng/mL	Sedation	Baseline: CBC (including WBC/ANC), LFTs, sodium; HLA-B*1502 testing in at-risk ancestry. Ongoing: periodic CBC, LFTs, and sodium; monitoring for rash and hyponatremia/SIADH. Serum levels: trough monitoring can be helpful in select cases; autoinduction and strong CYP induction create many drug interactions. Recheck serum level after 3–4 weeks on a stable dose to account for autoinduction, and again after adding or stopping strong CYP3A4 inhibitors/inducers. Medication reconciliation at each visit (oral contraceptives, warfarin or other anticoagulants, antipsychotics) because enzyme induction can lower exposure and change clinical response. Contraception interactions and rash/fever warning signs are typically reviewed.	No	2025-12-28
valproate (divalproex)Mood stabilizerBrands: DEPAKOTE View labelExact	Acute mania associated with bipolar disorder; seizures (various types). View labelExact	Acute mania: initiate 750–1,000 mg/day (divided TID for DR or once daily ER) and titrate to serum 50–125 µg/mL; loading up to 20–30 mg/kg/day can achieve rapid control.	Increases GABA; modulates voltage-gated sodium and calcium channels.	UGT, beta-oxidation \| Steady-state mean 12 h	50000–125000 ng/mL	Weight Sedation	Baseline: LFTs, CBC with platelets, pregnancy test if relevant, weight/BMI. Level timing: 12-hour trough (extended-release may differ); target 50–125 µg/mL based on clinical context. Ongoing: Periodic LFTs and CBC; monitor metabolic effects and sedation. Precautions: Reinforce teratogenicity counseling; review pancreatitis and hepatotoxicity warnings. Drug interactions: Adjust for enzyme induction (UGT), lamotrigine titration, and other interacting therapies.	No	2025-09-23

Compare tool FAQ

How many medications can I compare at once?

You can line up to four medications at a time. Use the search box to add or remove drugs, then press “Compare” to refresh the table.

Where does the comparison data come from?

Most fields are generated from our curated facts + per-drug profiles. DailyMed label links come from source metadata, and LAI options come from our LAI catalog.

Can I save or share a comparison?

Yes. The Share button copies a link you can send to teammates, and we store your most recent selection so you can restore it next time you visit.